On the other hand, anti-Ro52/SSA and anti-La/SSB have the highest relative risks of congenital heart block in offspring from anti-Ro/SSA positive patients because these two antigens are expressed in foetal cardiac tissue from the 18th to 24th week [272]. The gene discussed is TRIM21; the disease is congenital heart block.